Valuation Analysis of the Medical Beauty Industry Based on DCF Valuation

Kaixin Zhang

doi:10.54097/y6742v15

Authors

Kaixin Zhang

DOI:

https://doi.org/10.54097/y6742v15

Keywords:

Medical beauty Industry; Aimeike; cash flow discount model.

Abstract

Contemporarily, with the development of China people who live in China have increase income. People have more attention of their appearance and the pursuit of quality of life is getting higher and higher, that the medical beauty Industry develop rapidly. The companies develop vigorously because consumers demand continues to increase nowadays that many companies in the medical beauty industry have investment value. However, some scholars query that why the company in the medical beauty Industry have such high valuation. Therefore, this study examines the leading enterprise in the medical beauty Industry called Aimeike, by means of collect and sort out the relevant data of Aimeike, used the discounted future cash flow model to analyze the valuation about Aimeike, on this account reflects whether the overall valuation of the medical beauty industry is on the high side. In order to provide investors some investment orientation and this study will offer some examines for the companies in medical beauty industry. During the research, there are high valuations in the medical beauty industry.

Downloads

Download data is not yet available.

References

Sun Y, Yang X. The Present Situation and Reflection on the Development of Chinese Medical Cosmetology Industry. Frontiers in Medical Science Research, 2022, 4: 11.

Deng J. The Medical Aesthetics Industry: Strengthening Self-discipline, Compliance, and Quality Development are Imperative. Economic Information Daily, 2024, 4(16): 7.

Wang H. Investment Value Analysis of Listed Companies in China's Medical Aesthetics Industry. Hebei Finance University, 2022.

Mi M. Research on Value Evaluation of High tech Enterprises in the Medical Aesthetics Industry Based on DCF Method. Central University of Finance and Economics, 2022.

Chen C. William Aimee's High Valuation Trap. Dynamic analysis of the stock market, 2021, 21: 39.

Lin Z. Aimike's net profit for the first quarter is expected to increase by more than 20%. The "medical beauty three giants" are easy to find new tracks, but popular products are hard to find. Daily Economic News, 2024, 4(11): 8.

Fu S. Aimeke Actively Creating a Product Matrix. China Securities Journal, 2024, 3(20): A06.

Lurago M. Valuation Study of Aimike Company Based on DCF and B-S Real Options Models. Sichuan University, 2023.

Deng Q. Value Evaluation of Medical Aesthetics Consumables Enterprises Based on DCF and B-S Combination Model. Yunnan University of Finance and Economics, 2023.

Ye C, Li W, Ye Y, et al. Construction of Valuation System with Chinese Characteristics Based on Entropy Weight Method and K-means. Financial Engineering and Risk Management, 2023, 6(11): 7.